Structural Heart Devices Market Size & Growth Forecast 2027–2036, By Segments (Type), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Structural Heart Devices Market size was valued at USD 21.1 billion in 2026 and is anticipated to grow at a 12.83% CAGR from 2027 to 2036, exceeding USD 70.56 billion by 2036. The industry revenue for 2027 is estimated at USD 23.38 billion.
Get more details on this report
Request Free Sample ReportStructural Heart Devices Market Intelligence Snapshot
Regional Market Dynamics
- North America accounted for 55.13% of the market in 2026, supported by specialized cardiac centers, advanced procedures, and strong device utilization.
- Asia Pacific is projected to grow at a 10.74% CAGR as healthcare capacity improves and hospitals expand minimally invasive treatment capabilities.
Segment Momentum
- TAVR held a 56.07% market share in 2026 due to its less invasive approach, shorter recovery timelines, and alignment with hospital goals of improving treatment access and procedural efficiency.
- SAVR is the fastest-growing segment because it remains essential for patients with complex anatomy or disease profiles where surgical intervention offers greater procedural flexibility and clinical suitability.
Market Expansion Drivers
- Increasing prevalence of valvular heart disease driving transcatheter intervention adoption globally.
- Expanding minimally invasive TAVR procedures improving patient eligibility and outcomes.
- Advancements in imaging and device design enhancing procedural precision and safety.
Leading Market Participants
- Leading players in the structural heart devices market include Boston Scientific Corporation (United States), Medtronic plc (Ireland), Edwards Lifesciences Corporation (United States), Abbott Laboratories (United States), LivaNova PLC (United Kingdom), JenaValve Technology, Inc. (Germany), CardioKinetix, Inc. (United States), Terumo Corporation (Japan), W. L. Gore & Associates, Inc. (United States), Artivion, Inc. (United States).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 21.1 billion
- 2027 Estimated Market Size: USD 23.38 billion.
- Projected Market Size: USD 70.56 billion by 2036
- Growth Forecast: 12.83% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: TAVR (Transcatheter Aortic Valve Replacement) (Type)
- Emerging Opportunity Segment: SAVR (Surgical Aortic Valve Replacement) (Type)
Market Growth Drivers and Industry Trends
Increasing prevalence of valvular heart disease driving transcatheter intervention adoption globally
The growing prevalence of valvular heart disease is supporting the structural heart devices market as healthcare systems increasingly require effective interventions for patients with valve-related disorders. Conditions affecting the aortic and mitral valves can impair cardiac function and reduce quality of life, creating demand for procedures that restore or improve valve performance. Transcatheter approaches provide an important treatment option for patients who may face challenges with conventional open-heart procedures, encouraging wider adoption of catheter-based structural heart interventions across clinical settings.
Expanding minimally invasive TAVR procedures improving patient eligibility and outcomes
Increasing use of minimally invasive transcatheter aortic valve replacement is driving the structural heart devices market by extending valve intervention options to a broader range of patients. TAVR enables valve replacement through catheter-based techniques rather than conventional open surgery, which can reduce procedural invasiveness and support recovery. Continued clinical adoption and improvements in patient selection are also enabling physicians to consider transcatheter treatment for individuals with different levels of surgical risk, strengthening utilization of transcatheter valve technologies.
Advancements in imaging and device design enhancing procedural precision and safety
Technological progress in cardiac imaging and structural device engineering is creating stronger demand within the structural heart devices market by improving the planning, navigation, and execution of complex interventions. Advanced imaging provides clinicians with more detailed visualization of cardiac anatomy, supporting accurate device positioning and procedural assessment. At the same time, improvements in device design can enhance compatibility with individual anatomical characteristics and facilitate controlled deployment, helping clinicians manage technically demanding procedures with greater precision.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Increasing prevalence of valvular heart disease driving transcatheter intervention adoption globally | 2.00% | High | North America, Europe | High | Near Term |
| Expanding minimally invasive TAVR procedures improving patient eligibility and outcomes | 1.80% | High | North America | High | Near Term |
| Advancements in imaging and device design enhancing procedural precision and safety | 1.50% | Moderate | North America, Europe | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America held the largest share of the structural heart devices market, accounting for 55.13% in 2026. The region's strong position is supported by advanced healthcare infrastructure, broad access to specialized cardiovascular care, and the increasing adoption of minimally invasive procedures for structural heart conditions. Established clinical expertise and greater awareness among healthcare professionals and patients are also encouraging the use of transcatheter approaches as alternatives to conventional open-heart interventions. In addition, continued investment in cardiac care facilities and procedural technologies is strengthening the region's capacity to diagnose and treat complex heart conditions, sustaining demand for structural heart devices.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is expected to represent the fastest-growing regional market, driven by expanding healthcare infrastructure, improving access to advanced cardiac treatment, and rising awareness of structural heart disorders. Growing healthcare expenditure across emerging economies is supporting the modernization of hospitals and the availability of specialized cardiovascular services. The increasing adoption of minimally invasive treatment techniques, combined with a large patient population and improving diagnostic capabilities, is creating favorable conditions for market expansion. Greater availability of trained medical professionals and efforts to improve access to advanced cardiac care are further contributing to the region's growth potential.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Precision Cardiac InterventionGermany emphasizes structural heart procedures supported by strong clinical standards and widespread use of advanced cardiovascular technologies. Hospitals throughout Germany continue refining patient selection and procedural efficiency for minimally invasive interventions.
France 🇫🇷
Integrated Valve CareFrance supports the structural heart devices market by integrating multidisciplinary cardiac teams with modern valve intervention programs. Healthcare providers in France emphasize coordinated diagnosis, treatment planning, and long-term patient follow-up for structural heart disease.
Italy 🇮🇹
Hospital Procedure ModernizationItaly advances the structural heart devices market by modernizing cardiovascular treatment infrastructure and expanding minimally invasive procedural capabilities. Cardiac centers across Italy continue improving access to innovative structural heart interventions through specialized clinical expertise.
Japan 🇯🇵
Minimally Invasive Cardiac CareJapan promotes structural heart device adoption through minimally invasive treatment approaches suited to patients requiring reduced procedural burden. Healthcare institutions in Japan continue strengthening clinical pathways that support earlier intervention and improved recovery outcomes.
South Korea 🇰🇷
Specialized Cardiac CentersSouth Korea expands structural heart device utilization through specialized cardiovascular hospitals and advanced interventional cardiology capabilities. South Korea continues investing in clinical expertise and procedural technologies that support complex structural heart treatments.
United States 🇺🇸
Advanced Procedure AdoptionThe U.S. structural heart devices market prioritizes minimally invasive cardiac procedures supported by specialized treatment centers and advanced clinical expertise. Healthcare providers across the U.S. continue expanding access to catheter-based interventions for complex cardiovascular conditions.
Segment Leadership and Growth Trends
Structural Heart Devices Market Share (%), by Type, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportType Segment Analysis: TAVR (Transcatheter Aortic Valve Replacement) (Largest Segment) vs SAVR (Surgical Aortic Valve Replacement) (Fastest-Growing Segment)
In the structural heart devices market, TAVR (transcatheter aortic valve replacement) held the largest share of 56.07% in 2026, supported by increasing clinical adoption of minimally invasive approaches for valve replacement and the growing emphasis on procedures that can reduce the burden associated with conventional open surgery. TAVR has become an important treatment option for appropriate patients with aortic valve disease, with its less invasive procedural profile supporting continued utilization.
At the same time, SAVR (surgical aortic valve replacement) is advancing at a faster pace as surgical techniques, valve technologies, and patient selection continue to evolve, while established clinical expertise and its applicability across a broad range of cases sustain demand for surgical replacement procedures.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Type | SAVR (Surgical Aortic Valve Replacement), TAVR (Transcatheter Aortic Valve Replacement), Mitral Repair (Annuloplasty), LAAC (Left Atrial Appendage Closure) | TAVR (Transcatheter Aortic Valve Replacement) | SAVR (Surgical Aortic Valve Replacement) |
Competitive Landscape and Market Positioning
Key companies in the structural heart devices market:
1. Boston Scientific Corporation (United States)
2. Medtronic plc (Ireland)
3. Edwards Lifesciences Corporation (United States)
4. Abbott Laboratories (United States)
5. LivaNova PLC (United Kingdom)
6. JenaValve Technology Inc. (Germany)
7. CardioKinetix Inc. (United States)
8. Terumo Corporation (Japan)
9. W. L. Gore & Associates Inc. (United States)
10. Artivion Inc. (United States)
Innovation within the structural heart devices market is increasingly focused on minimally invasive treatment solutions and advanced implant technologies designed to improve cardiac care outcomes. Manufacturers are enhancing procedural precision through next-generation imaging compatibility and durable device materials that support long-term patient safety. Rising demand for less invasive cardiovascular interventions is also contributing to expansion opportunities across the structural heart devices market.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Boston Scientific Corporation (United States) | |||||||
| Medtronic plc (Ireland) | |||||||
| Edwards Lifesciences Corporation (United States) | |||||||
| Abbott Laboratories (United States) | |||||||
| LivaNova PLC (United Kingdom) | |||||||
| JenaValve Technology Inc. (Germany) | |||||||
| CardioKinetix Inc. (United States) | |||||||
| Terumo Corporation (Japan) | |||||||
| W. L. Gore & Associates Inc. (United States) | |||||||
| Artivion Inc. (United States). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| UPMC’s Heart and Vascular Institute | Apr-25 | UPMC’s Heart and Vascular Institute in Central Pa. was the first in Pennsylvania to perform a valve-in-valve TAVR using a newly FDA-approved leaflet-modification device designed to reduce the risk of coronary obstruction in high-risk patients. |
| LUMA Vision | Apr-25 | LUMA Vision secured FDA clearance for its VERAFEYE platform, offering real-time 360° catheter navigation support for structural heart and electrophysiology procedures. |
| Pi-Cardia | Nov-24 | Pi-Cardia’s innovative Shortcut system received De Novo authorization from the U.S. Food and Drug Administration (FDA). This novel device is designed to support valve-in-valve Transcatheter Aortic Valve Replacement (TAVR) procedures by addressing a critical coronary obstruction complication. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Structural Heart Devices Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Patient Risk Profile | Low-Risk Patients, Intermediate-Risk Patients, High-Risk Patients, Extreme-Risk Patients |
| Treatment Setting | Inpatient Hospitals, Outpatient Cardiac Centers, Ambulatory Surgical Centers |
| Payer & Reimbursement Type | Public Insurance, Private Insurance, Self-Pay |
Structural Heart Devices Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Hospital Center of Excellence Benchmarking |
|
| Physician Adoption & Training Landscape |
|
| Reimbursement & Market Access Opportunity Assessment |
|
Need a different cut of the data?
Request Custom ResearchWhat is the current size of the structural heart devices market?
What is the projected value of the structural heart devices industry by 2036?
How is the expansion of minimally invasive TAVR procedures reshaping demand in the structural heart devices market?
Why are advancements in imaging and device design critical to adoption in the structural heart devices market?
Why is TAVR the leading segment in the structural heart devices market?
What is driving growth in the SAVR segment?
What factors support North America’s dominance in structural heart devices?
Where is structural heart device adoption expanding fastest?
Who are the leading players in the structural heart devices landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization